Hinge Health, Inc. HNGE 深 沪
已收盘 12-12 16:00:00 美东时间
49.70
-0.090
-0.18%
华盛通- 最 高50.29
- 今 开49.72
- 成交量 88.64万股
- 最 低 49.29
- 昨 收 49.79
- 总市值 38.98亿
- 52周最高 62.18
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 33.4228
- 委 比 -45.63%
- 总股本 7843.52万
- 历史最高 62.18
- 量 比 0.58
- 振 幅 2.01%
- 历史最低 33.4228
- 每 手 1
- 风险率 6.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dycom Industries, BellRing Brands, Lumentum And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points ...
11-20 01:02
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Piper Sandler Reiterates Overweight on Hinge Health, Raises Price Target to $71
Piper Sandler analyst Jessica Tassan reiterates Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $70 to $71.
11-05 23:45
Hinge Health shares are trading lower. The company reported Q3 financial results.
Hinge Health shares are trading lower. The company reported Q3 financial result...
11-05 05:46
Earnings Scheduled For November 4, 2025
Companies Reporting Before The Bell • Sequans Communications (NYSE:SQNS) is lik...
11-04 19:12
Trump Administration Review Targets Medical Supply Chain Vulnerabilities
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign suppliers for critical health products.
09-26 02:07
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $67
Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $57 to $67.
09-23 23:39
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
Baird Initiates Coverage On Hinge Health with Neutral Rating, Announces Price Target of $56
Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price Target of $56.
09-05 19:09
